{
    "Trade/Device Name(s)": [
        "Evidence MultiSTAT DOA Urine Multiplex",
        "Evidence MultiSTAT Urine DOA MultiPlex",
        "Evidence MultiSTAT"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K220451",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091454"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DJC",
        "JXM",
        "DJR",
        "JJE"
    ],
    "Summary Letter Date": "March 7, 2023",
    "Summary Letter Received Date": "April 14, 2023",
    "Submission Date": "October 4, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3610",
        "21 CFR 862.3170",
        "21 CFR 862.3620",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Opiate Test System",
        "Methamphetamine Test System",
        "Benzodiazepine Test System",
        "Methadone Test System",
        "Analyzer, Chemistry (Photometric, Discrete), For Clinical Use"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Methamphetamine",
        "Noroxycodone",
        "Oxazepam",
        "Methadone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Evidence MultiSTAT"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive immunoassay",
        "Chemiluminescent detection",
        "Biochip array"
    ],
    "Methodologies": [
        "Qualitative",
        "Competitive immunoassay",
        "Chemiluminescent biochip array"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Kit",
        "Cartridge",
        "Reagent",
        "Accessory",
        "Buffer",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Evidence MultiSTAT DOA Urine Multiplex for qualitative determination of drugs of abuse in urine using competitive chemiluminescent immunoassay on the Evidence MultiSTAT analyzer.",
    "Indications for Use Summary": "Qualitative determination of parent drug molecules and metabolites in human urine at established cut-offs for drugs of abuse; for preliminary analytical results to be confirmed by specific alternative chemical methods.",
    "fda_folder": "Toxicology"
}